Hardy Diagnostics Now Offers the BioCode® MDx-3000
14 mars 2022 07h00 HE | Hardy Diagnostics
SANTA MARIA, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics, a leader in manufactured and distributed microbiology products, is pleased to announce it is now the exclusive distributor...
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
17 févr. 2021 17h13 HE | BioNTech SE
New York, NY and Mainz, Germany, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study that provides additional...
Im The New England Journal of Medicine veröffentlichte in-vitro-Daten zeigen, dass Seren von mit dem Pfizer-BioNTech COVID-19-Impfstoff geimpften Personen SARS-CoV-2 mit der Südafrika-Spike-Mutation neutralisieren
17 févr. 2021 17h13 HE | BioNTech SE
New York, USA und Mainz, DEUTSCHLAND, 17. Februar 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute Ergebnisse einer in-vitro-Studie bekannt, die zusätzliche...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
21 déc. 2020 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the...
QUALITY Bizcapstacked.JPG
Business Capital Delivers Financing for Bay Area Medical Clinic
12 févr. 2020 05h00 HE | Business Capital
SAN FRANCISCO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Business Capital structured and delivered approximately $6MM in senior secured loans for NOVA IVF, a clinic established in 1987, providing in vitro...
Predictive Technology Group, Inc. (PRED) Announces Completion of Genotyping in Two Clinical Trials of ARTGuide™
SALT LAKE CITY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Predictive Therapeutics, LLC, its wholly-owned subsidiary, completed a crucial...
Earth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical Patents
14 nov. 2017 08h00 HE | Earth Science Tech, Inc.
Doral, Nov. 14, 2017 (GLOBE NEWSWIRE) --  Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of industrial hemp...
Bob Woodruff Foundation
Bob Woodruff Foundation Establishes Interim Funding for Injured Veteran IVF Services
18 oct. 2016 09h08 HE | Bob Woodruff Foundation
NEW YORK, Oct. 18, 2016 (GLOBE NEWSWIRE) -- The Bob Woodruff Foundation celebrates the culmination of months of work by Congress and advocacy by multiple veteran serving organizations. Congressional...
Fate Therapeutics.jpg
Fate Therapeutics Announces Preclinical Data Highlighting Persistent Effector Function of Allogeneic Natural Killer Cell Cancer Immunotherapy
16 mai 2016 08h01 HE | Fate Therapeutics, Inc.
Adaptive NK Cell Therapy Advancing Toward First-in-Human Clinical Trial in Collaboration with University of Minnesota Program to be Presented Today at Innate Killer Summit 2016 SAN DIEGO, May 16,...
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS)
16 juin 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, June 16, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced that a new publication (June 2, 2014) in the Formulary Journal...